Vivoryon Therapeutics NV (VVY) — Financial Flexibility Index
Vivoryon Therapeutics NV (VVY) has a Financial Flexibility Index of -1.42x as of December 2025. Free cash flow of €-3.96 Million (operating CF €-3.96 Million minus capex €2.00K) represents -1% of total liabilities (€2.79 Million). Also explore Vivoryon Therapeutics NV net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vivoryon Therapeutics NV Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Vivoryon Therapeutics NV across 15 annual periods. Check Vivoryon Therapeutics NV (VVY) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Vivoryon Therapeutics NV (2011–2025)
Year-by-year free cash flow to debt coverage for Vivoryon Therapeutics NV. For the full company profile including market capitalisation, see Vivoryon Therapeutics NV stock valuation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.03x | €-8.45 Million | €-8.46 Million | €2.79 Million | ▲ +46.3% |
| 2024 | -5.63x | €-19.17 Million | €-19.17 Million | €3.40 Million | ▼ -21.8% |
| 2023 | -4.62x | €-21.03 Million | €-21.54 Million | €4.55 Million | ▼ -3.4% |
| 2022 | -4.47x | €-21.78 Million | €-21.79 Million | €4.87 Million | ▼ -217.0% |
| 2021 | -1.41x | €-11.23 Million | €-11.26 Million | €7.96 Million | ▲ +62.8% |
| 2020 | -3.79x | €-13.37 Million | €-14.01 Million | €3.53 Million | ▼ -4.7% |
| 2019 | -3.62x | €-11.56 Million | €-11.61 Million | €3.20 Million | ▼ -46.1% |
| 2018 | -2.48x | €-6.98K | €-6.99K | €2.82K | ▲ +62.4% |
| 2017 | -6.59x | €-12.11K | €-12.12K | €1.84K | ▼ -197.7% |
| 2016 | -2.21x | €-13.25K | €-13.26K | €5.99K | ▼ -4.4% |
| 2015 | -2.12x | €-12.14K | €-12.15K | €5.73K | ▼ -10.2% |
| 2014 | -1.92x | €-10.59K | €-10.59K | €5.51K | ▼ -140.7% |
| 2013 | -0.80x | €-8.46 Million | €-8.53 Million | €10.60 Million | ▲ +68.9% |
| 2012 | -2.57x | €-11.92 Million | €-12.04 Million | €4.64 Million | ▲ +25.1% |
| 2011 | -3.43x | €-14.22 Million | €-14.32 Million | €4.15 Million | — |